precisionmedicineonline10h
PTC Therapeutics' AADC Deficiency Gene Therapy Kebilidi Gains FDA Accelerated Approval
This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.
Potential Tropical Cyclone 19 forms over Caribbean Sea, models show potential Florida impacts
The National Hurricane Center is monitoring Potential Tropical Cyclone 19, which could impact Florida sometime next week | ...
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the 'Company'), a global therapy-enabling platform company ...
PTC19 forms in the Caribbean and could bring impacts here next Wednesday.
Chief meteorologist Tony Mainolfi has Central Florida's updated forecast. PTC19 forms in the Caribbean and could bring ...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...
PTC Therapeutics: Balancing Growth Opportunities and Risks with Hold Rating
Analyst Jeffrey Hung of Morgan Stanley maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), retaining the price target ...